Incannex to Participate in the Prestigious H.C. Wainwright 24th Annual Global Investment Conference MELBOURNE, Australia, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing medicinal...

Incannex Appoints FDA Regulatory Affairs Expert Mr Robert B. Clark to the Board of Directors Highlights: Highly experienced pharmaceutical executive with 20+ years at Pfizer and 10+ years at Novo NordiskSecured FDA registration and marketing approval for 12 significant new drugs in the past...